Information  X 
Enter a valid email address

M&G PLC (MNG)

  Print      Mail a friend

Thursday 19 March, 2020

M&G PLC

Director/PDMR Shareholding

RNS Number : 7814G
M&G PLC
19 March 2020
 

M&G plc NEWS RELEASE
19 March 2020

M&G plc

Notification of transaction by Person Discharging Managerial Responsibilities (PDMR)

M&G plc announces that Mike Evans, Chair, purchased 51,627 ordinary shares of 5 pence each on 18 March 2020.

The notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provides further detail.

Contact

Alan Porter, Group General Counsel and Company Secretary - 0203 977 4064

 

Helen Archbold, Head of Secretariat - 0203 977 0057

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mike Evans

2

Reason for the notification

a)

Position/status

Chair

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M&G plc 

b)

LEI

254900TWUJUQ44TQJY84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 


GB00BKFB1C65

 b) 

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price (s)

Volume (s)

£0.9685

51,627

 

 

Aggregated information

 

-Aggregated volume

 

-Price

 

 

51,627

 

£0.9685

 

Date of the transaction

2020-03-18

 

Place of the transaction

XLON

LEI: 254900TWUJUQ44TQJY84

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHSFISUUESSEFD

a d v e r t i s e m e n t